This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 May 2;66(10):1639.

doi: 10.1093/cid/cix1089.

Procalcitonin as a Marker of Etiology in Community-Acquired Pneumonia

Michael S Abers^{1

2}, Daniel M Musher^{3

4

5}

Affiliations

Affiliations

¹ Division of Infectious Diseases, Massachusetts General Hospital, Houston, Texas.
² Department of Medicine, Harvard Medical School, Boston, Massachusetts, Houston, Texas.
³ Department of Medicine, Baylor College of Medicine, Houston, Texas.
⁴ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
⁵ Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

PMID: 29360957
DOI: 10.1093/cid/cix1089

Comment

Procalcitonin as a Marker of Etiology in Community-Acquired Pneumonia

Michael S Abers et al. Clin Infect Dis. 2018.

. 2018 May 2;66(10):1639.

doi: 10.1093/cid/cix1089.

Authors

Michael S Abers^{1

2}, Daniel M Musher^{3

4

5}

Affiliations

¹ Division of Infectious Diseases, Massachusetts General Hospital, Houston, Texas.
² Department of Medicine, Harvard Medical School, Boston, Massachusetts, Houston, Texas.
³ Department of Medicine, Baylor College of Medicine, Houston, Texas.
⁴ Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
⁵ Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.

PMID: 29360957
DOI: 10.1093/cid/cix1089

No abstract available

PubMed Disclaimer

Comment in

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
Self WH, Wunderink RG, Jain S, Edwards KM, Grijalva CG; Etiology of Pneumonia in the Community (EPIC) Study Investigators. Self WH, et al. Clin Infect Dis. 2018 May 2;66(10):1640-1641. doi: 10.1093/cid/cix1090. Clin Infect Dis. 2018. PMID: 29360954 No abstract available.

Comment on

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
Self WH, Balk RA, Grijalva CG, Williams DJ, Zhu Y, Anderson EJ, Waterer GW, Courtney DM, Bramley AM, Trabue C, Fakhran S, Blaschke AJ, Jain S, Edwards KM, Wunderink RG. Self WH, et al. Clin Infect Dis. 2017 Jul 15;65(2):183-190. doi: 10.1093/cid/cix317. Clin Infect Dis. 2017. PMID: 28407054 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information